Cormedix Inc (CRMD)
4.24
+0.08
(+1.92%)
USD |
NASDAQ |
Mar 28, 16:00
4.235
0.00 (0.00%)
After-Hours: 20:00
Cormedix Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.4088 |
March 31, 2019 | 0.3886 |
December 31, 2018 | 1.241 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
Date | Value |
---|---|
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Sep 2019
0.4088
Maximum
Jun 2019
0.0498
Average
--
Median
Sep 2019
Debt to Equity Ratio Benchmarks
Johnson & Johnson | 0.4265 |
Bristol-Myers Squibb Co | 1.351 |
BioXcel Therapeutics Inc | -1.780 |
ACADIA Pharmaceuticals Inc | 0.00 |
Amicus Therapeutics Inc | 2.422 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 82.06M |
Total Liabilities (Quarterly) | 11.92M |
Shareholders Equity (Quarterly) | 70.14M |